Kadmon Holdings Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Kadmon Holdings Inc.

Kadmon Holdings Inc. | Ownership

Companies that own Kadmon Holdings Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Perceptive Advisors LLC

13,165,746

11.64%

8,000,000

1.29%

06/30/2018

Third Point LLC

9,407,745

8.32%

0.22%

06/30/2018

Acuta Capital Partners LLC

9,060,014

8.01%

3,110,014

6.81%

06/30/2018

BlackRock Fund Advisors

4,418,237

3.91%

2,891,308

06/30/2018

The Vanguard Group, Inc.

4,100,534

3.63%

1,199,052

06/30/2018

Puissance Capital Management LP

4,095,000

3.62%

670,000

11.14%

06/30/2018

Marshall Wace North America LP

2,966,655

2.62%

841,615

0.07%

06/30/2018

Ecor1 Capital LLC

2,500,000

2.21%

2,500,000

1.12%

06/30/2018

Ghost Tree Capital LLC

1,900,000

1.68%

300,000

2.24%

06/30/2018

Marshall Wace LLP

1,704,894

1.51%

662,773

0.09%

06/30/2018

About Kadmon Holdings

View Profile

Address	450 East 29th Street New York New York 10016 United States
Employees	-
Website	http://www.kadmon.com
Updated	07/08/2019
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N.